---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-023417"
form_type: "8-K"
ticker: "INFU"
cik: "0001337013"
company_name: "InfuSystem Holdings, Inc"
filed_at: "2025-05-08T23:59:59+00:00"
generated_at: "2026-05-22T03:35:59.426009+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# InfuSystem Q1 revenue $34.7M (+9% YoY); Adj. EBITDA $6.3M (+64%)

## Summary
- Net revenue $34.7M (+9% YoY); net loss narrowed to $0.3M ($0.01 loss per share) from $1.1M.
- Adjusted EBITDA $6.3M (+64% YoY); margin expanded 6.2pp to 18.2%.
- Patient Services revenue up 12% to $20.8M; Device Solutions up 4% to $13.9M.
- FY 2025 guidance reaffirmed: revenue growth 8-10%; Adj. EBITDA margin high teens.
- CEO transition: Richard DiIorio out; Carrie Lachance (COO) incoming; $1.0M severance accrued.

## SEC filing metadata
- accession: 0001628280-25-023417
- form_type: 8-K
- ticker: INFU
- cik: 0001337013
- company_name: InfuSystem Holdings, Inc
- filed_at: 2025-05-08T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1337013/000162828025023417/0001628280-25-023417-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1337013/000162828025023417/infu-20250508.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-023417
- JSON: https://secwatch.observer/filing/0001628280-25-023417.json
- Plain text: https://secwatch.observer/filing/0001628280-25-023417.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.